BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18502482)

  • 21. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy.
    Izawa JI; Perrotte P; Greene GF; Scott S; Levy L; McGuire E; Madsen L; von Eschenbach AC; Pisters LL
    J Urol; 2001 Mar; 165(3):867-70. PubMed ID: 11176488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
    Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
    Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.
    Nichol A; Chung P; Lockwood G; Rosewall T; Divanbiegi L; Sweet J; Toi A; Bayley A; Bristow R; Crook J; Gospodarowicz M; McLean M; Milosevic M; Warde P; Catton C
    Radiother Oncol; 2005 Jul; 76(1):11-7. PubMed ID: 15990187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An algorithm for managing the failure of external beam radiotherapy in prostate cancer.
    Dudderidge T; Payne H; Emberton M
    BJU Int; 2007 Sep; 100(3):518-27. PubMed ID: 17573894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control.
    De Meerleer GO; Fonteyne VH; Vakaet L; Villeirs GM; Denoyette L; Verbaeys A; Lummen N; De Neve WJ
    Radiother Oncol; 2007 Feb; 82(2):160-6. PubMed ID: 17222931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
    Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy.
    Ho AY; Burri RJ; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):16-22. PubMed ID: 19289266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
    Pisters LL; Leibovici D; Blute M; Zincke H; Sebo TJ; Slezak JM; Izawa J; Ward JF; Scott SM; Madsen L; Spiess PE; Leibovich BC
    J Urol; 2009 Aug; 182(2):517-25; discussion 525-7. PubMed ID: 19524984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.
    Al-Mamgani A; Heemsbergen WD; Peeters ST; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):685-91. PubMed ID: 18718725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.
    Nobes JP; Wells IG; Khaksar SJ; Money-Kyrle JF; Laing RW; Langley SE
    Prostate Cancer Prostatic Dis; 2009; 12(1):61-6. PubMed ID: 18427571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Zapatero A; Mínguez R; Nieto S; Martín de Vidales C; García-Vicente F
    Eur Urol; 2009 Apr; 55(4):902-9. PubMed ID: 18485578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.
    Al-Mamgani A; van Putten WL; Heemsbergen WD; van Leenders GJ; Slot A; Dielwart MF; Incrocci L; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):980-8. PubMed ID: 18495377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.
    Pommier P; Chabaud S; Lagrange JL; Richaud P; Lesaunier F; Le Prise E; Wagner JP; Hay MH; Beckendorf V; Suchaud JP; Pabot du Chatelard PM; Bernier V; Voirin N; Perol D; Carrie C
    J Clin Oncol; 2007 Dec; 25(34):5366-73. PubMed ID: 18048817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
    Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
    Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.